Compound ID | 2165
Class: Antimicrobial peptide
| Agent Type: | Natural product; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against Pseudomonas aeruginosa |
| Description: | Pyocin S5 showed significantly increased survival in both Galleria mellonella systemic infection and septic mouse model; bacteriocin-type |
| Year first mentioned: | 2021 |
| Development status: | Experimental |